FB
TEVA icon

First Bancorp’s Teva Pharmaceuticals TEVA Stock Holding History

First Bancorp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
+5,380
New +$179K 0.07% 148

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

First Bancorp's TEVA Position: Q2 2026 in Review

First Bancorp opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 5,380 shares worth $182K. The stake represents 0.07% of the portfolio and ranks #148 among its holdings.

672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • First Bancorp held 5,380 shares of Teva Pharmaceuticals worth $182K as of Q2 2026.
  • Teva Pharmaceuticals was a new First Bancorp position in Q2 2026.
  • Teva Pharmaceuticals made up 0.07% of First Bancorp's portfolio in Q2 2026, its #148 holding.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on First Bancorp's 13F filing for Q2 2026, filed 11 Aug 2026.